Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters











Database
Language
Publication year range
1.
JSLS ; 13(4): 601-4, 2009.
Article in English | MEDLINE | ID: mdl-20042130

ABSTRACT

BACKGROUND: Laparoscopic splenectomy has been performed in a standard fashion with 4 to 5 trocars since the early 1990s. Single access laparoscopy has recently gained interest, but single access laparoscopic splenectomy has not been reported to date. It has the possible benefits of less pain, faster recovery, better cosmesis, with theoretically similar costs to that of traditional trocars. METHODS: A case is presented and the surgical technique of single access laparoscopic splenectomy is detailed. RESULTS: The patient is an otherwise healthy 24-year-old male with medically refractory idiopathic thrombocytopenic purpura and a platelet count of 15 000. A splenectomy was performed using a single incision laparoscopic technique. The patient was placed in a right lateral decubitus position, and a 2.5-cm left upper quadrant incision was made. A multi-instrument flexible single incision port was used that held 3 trocars. A standard splenectomy was performed through this port. A linear stapler was used to transect the splenic hilum. The procedure time was just over 2 hours. The patient did well, was happy with his incision, and was discharged with a platelet count of 108 000. CONCLUSIONS: Single access laparoscopic splenectomy is feasible in select patients and may provide a less painful, better cosmetic result.


Subject(s)
Laparoscopy/methods , Purpura, Thrombocytopenic, Idiopathic/surgery , Splenectomy/methods , Humans , Male , Platelet Count , Young Adult
2.
Plast Reconstr Surg ; 120(7): 1783-1795, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18090740

ABSTRACT

BACKGROUND: Cranial skeletogenic mesenchyme is derived from two distinct embryonic sources: mesoderm and cranial neural crest. Previous studies have focused on molecular and cellular differences of juvenile and adult osteoblasts. METHODS: To further understand the features of mouse-derived juvenile osteoblasts, the authors separated calvarial osteoblasts by their developmental origins: frontal bone-derived osteoblasts from cranial neural crest, and parietal bone-derived osteoblasts from paraxial mesoderm. Cells were harvested from a total of 120 mice. RESULTS: Interestingly, the authors observed distinct morphologies and proliferation potential of the two populations of osteoblasts. Osteogenic genes such as alkaline phosphatase, osteopontin, collagen I, and Wnt5a, which was recently identified as playing a role in skeletogenesis, were abundantly expressed in parietal bone-derived osteoblasts versus frontal bone-derived osteoblasts. In addition, fibroblast growth factor (FGF) receptor 2, and FGF-18 were more highly expressed in the parietal bone-derived osteoblasts, suggesting a more differentiated phenotype. In contrast, FGF-2, and adhesion molecules osteoblast cadherins and bone morphogenetic protein receptor IB, the bone tissue-specific type receptor were overexpressed in frontal bone-derived osteoblasts compared with parietal bone-derived osteoblasts. CONCLUSIONS: The authors observed that although neural crest-derived osteoblasts represented a population of less differentiated, faster growing cells, they formed bone nodules more rapidly than parietal bone-derived osteoblasts. This in vitro study suggests that embryonic tissue derivations influence postnatal in vitro calvarial osteoblast cell biology.


Subject(s)
Frontal Bone/cytology , Mesoderm/cytology , Neural Crest/cytology , Osteoblasts/cytology , Osteogenesis/physiology , Parietal Bone/cytology , Alkaline Phosphatase/analysis , Animals , Cell Adhesion , Cell Differentiation , Cell Division , Cell Lineage , Cell Separation , Cells, Cultured/cytology , Cells, Cultured/drug effects , Frontal Bone/embryology , Frontal Bone/growth & development , Gene Expression Profiling , Intercellular Signaling Peptides and Proteins/biosynthesis , Intercellular Signaling Peptides and Proteins/genetics , Mice , Organ Specificity , Osteoblasts/classification , Osteoblasts/metabolism , Osteogenesis/genetics , Parietal Bone/embryology , Parietal Bone/growth & development , Receptors, Growth Factor/biosynthesis , Receptors, Growth Factor/genetics , Wnt Proteins/biosynthesis , Wnt Proteins/genetics , Wnt-5a Protein
3.
Tissue Eng ; 13(12): 2981-93, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17916040

ABSTRACT

Cartilage is an avascular tissue, and chondrocytes in vivo experience a severely hypoxic environment. Using a defined in vitro model of early chondrogenesis, we attempted to enrich for cells with an enhanced ability for chondrogenic differentiation by pre-exposure of mouse adipose-derived adult stromal cells (ADASs) to a hypoxic (2% oxygen) environment. ADASs were subsequently expanded in 2% or 21% oxygen environments, resulting in 2 groups of cells, and then early chondrogenic differentiation was induced at 21% oxygen tension using a 3-dimensional micromass culture system. ADAS chondrogenesis was assessed using Alcian Blue staining for proteoglycans and quantification of sulfated glycosaminoglycans. Osteogenesis of the 2 cell groups was also studied. Two percent oxygen tension profoundly increased the proliferation of ADASs. ADASs expanded in 2% oxygen tension exhibited enhanced early chondrogenic differentiation and diminished osteogenesis, suggesting that the reduced oxygen environment may favor chondroprogenitors. Gene expression analysis suggested that matrix metalloproteinase synthesis was inhibited in cells expanded in 2% oxygen. Furthermore, re-oxygenation of the 2% oxygen-expanded ADASs before differentiation did not significantly affect early chondrogenesis. Thus, priming ADASs with 2% oxygen may have selected for chondrogenic progenitors with an enhanced ability to survive and differentiate. This study is relevant for the future application of cell-based therapies involving cartilage tissue regeneration.


Subject(s)
Adipocytes/cytology , Adipocytes/physiology , Chondrocytes/cytology , Chondrocytes/physiology , Chondrogenesis/physiology , Oxygen/metabolism , Tissue Engineering/methods , Animals , Cell Culture Techniques/methods , Cell Differentiation , Cell Hypoxia/physiology , Cells, Cultured , Mice , Stromal Cells/cytology , Stromal Cells/physiology
4.
Tissue Eng ; 13(6): 1159-71, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17518738

ABSTRACT

Increased cartilage-related disease, poor regeneration of cartilage tissue, and limited treatment options have led to intense research in tissue engineering of cartilage. Adipose-derived adult stromal cells (ADAS) are a promising cell source for skeletal tissue engineering; understanding ADAS cellular signaling and chondrogenesis will advance cell-based therapies in cartilage repair. Chondrocytes are unique-they are continuously challenged by a hypoxic microenvironment. Hypoxia inducible factor-1-alpha (HIF-1alpha), a critical mediator of a cell's response to hypoxia, plays a significant role in chondrocyte survival, growth arrest, and differentiation. By using an established in vitro 3-dimensional micromass system, we investigated the role of HIF-1alpha in chondrogenesis. Targeted deletion of HIF-1alpha in ADAS substantially inhibited the chondrogenic pathway specifically. In marked contrast, deletion of HIF-1alpha did not affect osteogenic differentiation but enhanced adipogenic differentiation. This study demonstrates the critical and specific interplay between HIF-1alpha and chondrogenesis in vitro.


Subject(s)
Adipocytes/cytology , Adipocytes/metabolism , Chondrocytes/cytology , Chondrocytes/metabolism , Chondrogenesis/physiology , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Tissue Engineering/methods , Animals , Cell Culture Techniques/methods , Cell Hypoxia , Cells, Cultured , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Male , Mice , Mice, Transgenic , Stromal Cells/cytology , Stromal Cells/metabolism
5.
Plast Reconstr Surg ; 119(3): 819-29, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17312483

ABSTRACT

BACKGROUND: Craniosynostosis, the premature fusion of cranial sutures, affects one in 2500 children. In the mouse, the posterofrontal suture is programed to fuse postnatally, but the adjacent sagittal suture remains patent throughout life. To study the cellular process of suture fusion, the authors isolated and studied suture-derived mesenchymal cells. METHODS: Skulls were harvested from 80 mice (2 to 5 days old), and posterofrontal and sagittal sutures were dissected meticulously. Suture mesenchymal tissue was separated from the underlying dura mater and overlying pericranium and cultured in growth media. After the cells migrated from the explant tissues, the morphologies of the two cell populations were studied carefully, and quantitative real-time polymerase chain reaction was performed to evaluate gene expression. RESULTS: Both posterofrontal and sagittal cells exhibited highly heterogeneous morphologies, and the posterofrontal cells migrated faster than the sagittal cells. Accordingly, growth factors such as transforming growth factor-beta1 and fibroblast growth factor (FGF)-2 were expressed significantly more highly in posterofrontal compared with sagittal suture mesenchymal cells. In contrast, FGF receptor 2 and FGF-18 were expressed significantly more in sagittal than in posterofrontal suture cells. Importantly, bone morphogenic protein-3, the only osteogenic inhibitor in the bone morphogenic protein family, and noggin, a bone morphogenic protein antagonist, were expressed significantly more in sagittal than in posterofrontal suture cells, suggesting a possible mechanism of suture patency. CONCLUSIONS: To the authors' knowledge, this is the first analysis of mouse suture-derived mesenchymal cells. The authors conclude that isolation of suture-derived mesenchymal cells will provide a useful in vitro system with which to study the mechanisms underlying suture biology.


Subject(s)
Cranial Sutures/cytology , Mesoderm/cytology , Animals , Bone Morphogenetic Protein 3 , Bone Morphogenetic Proteins/antagonists & inhibitors , Bone Morphogenetic Proteins/metabolism , Carrier Proteins/metabolism , Cell Movement , Cells, Cultured , Chondrogenesis , Craniosynostoses/pathology , Craniosynostoses/physiopathology , Dura Mater/cytology , Dura Mater/physiology , Fibroblast Growth Factor 2/genetics , Fibroblast Growth Factor 2/metabolism , Fibroblast Growth Factors/metabolism , Gene Expression , Immunohistochemistry , Mesoderm/metabolism , Mesoderm/physiology , Mice , Mice, Inbred Strains , Osteogenesis , Polymerase Chain Reaction , RNA, Messenger/metabolism , Receptor, Fibroblast Growth Factor, Type 2/metabolism , Transforming Growth Factor beta1/metabolism
6.
Tissue Eng ; 12(7): 2031-40, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16889531

ABSTRACT

Adipose-derived mesenchymal cells (AMCs) offer great promise for tissue engineering of bone. Previously, 1,25-dihydroxyvitamin D3, retinoic acid (RA), and dexamethasone had been shown to promote osteogenesis in bone marrow-derived mesenchymal cells (BMSCs). To study the osteogenic characteristics of mouse AMCs, we applied these 3 hormones alone and in combination to the AMCs and examined markers of osteogenic differentiation. Interestingly, vitamin D and RA demonstrated a consistent, dose-dependent enhancement of osteogenesis and upregulated osteoblast specific markers including osteopontin and osteocalcin. However, in AMCs, dexamethasone clearly inhibited osteogenic differentiation in a dose dependent fashion and greatly increased the adipogenic marker peroxisome proliferator activated receptor gamma (PPAgamma). In summary, we show in vitro that vitamin D and RA are potential candidates to serve as enhancers of osteogenesis of AMCs and may be incorporated into future cell-based strategies for bone tissue engineering.


Subject(s)
Adipose Tissue/metabolism , Antineoplastic Agents/pharmacology , Bone Density Conservation Agents/pharmacology , Calcitriol/pharmacology , Dexamethasone/pharmacology , Osteogenesis/drug effects , Tretinoin/pharmacology , Adipose Tissue/cytology , Animals , Antigens, Differentiation/biosynthesis , Cell Differentiation/drug effects , Cells, Cultured , Male , Mice , Tissue Engineering , Up-Regulation/drug effects
7.
Am J Physiol Cell Physiol ; 290(4): C1139-46, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16291817

ABSTRACT

Recent studies have demonstrated that adipose-derived mesenchymal cells (AMCs) offer great promise for cell-based therapies because of their ability to differentiate toward bone, cartilage, and fat. Given that cartilage is an avascular tissue and that mesenchymal cells experience hypoxia during prechondrogenic condensation in endochondral ossification, the goal of this study was to understand the influence of oxygen tension on AMC differentiation into bone and cartilage. In vitro chondrogenesis was induced using a three-dimensional micromass culture model supplemented with TGF-beta1. Collagen II production and extracellular matrix proteoglycans were assessed with immunohistochemistry and Alcian blue staining, respectively. Strikingly, micromasses differentiated in reduced oxygen tension (2% O(2)) showed markedly decreased chondrogenesis. Osteogenesis was induced using osteogenic medium supplemented with retinoic acid or vitamin D and was assessed with alkaline phosphatase activity and mineralization. AMCs differentiated in both 21 and 2% O(2) environments. However, osteogenesis was severely diminished in a low-oxygen environment. These data demonstrated that hypoxia strongly inhibits in vitro chondrogenesis and osteogenesis in AMCs.


Subject(s)
Adipose Tissue/cytology , Cell Differentiation , Chondrogenesis/physiology , Mesenchymal Stem Cells/physiology , Osteogenesis/physiology , Oxygen/metabolism , Adipose Tissue/physiology , Alkaline Phosphatase/metabolism , Animals , Cells, Cultured , Collagen Type II/metabolism , Extracellular Matrix/chemistry , Glycosaminoglycans/chemistry , Glycosaminoglycans/metabolism , Hypoxia , Male , Mesenchymal Stem Cells/cytology , Mice , Proteoglycans/metabolism , Tretinoin/metabolism , Vitamin D/metabolism
9.
Curr Opin Mol Ther ; 7(4): 300-5, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16121695

ABSTRACT

Recent studies suggest that adipose tissue contains pluripotent cells that are similar to those derived from other tissues, such as bone marrow. Mesenchymal cells isolated from adipose tissue are capable of differentiating along osteogenic, chondrogenic, myogenic, adipogenic and possibly neuronal lineages. Current knowledge of adipose-derived mesenchymal cells is reviewed, with a particular focus on efforts to direct these cells towards bone formation. Cell-based therapies using adipose tissue are anticipated to be of great clinical interest for skeletal tissue repair and regeneration.


Subject(s)
Adipose Tissue/cytology , Cell Differentiation , Mesenchymal Stem Cell Transplantation , Osteogenesis/physiology , Regeneration/physiology , Animals , Cell Proliferation , Chondrocytes/physiology , Humans , Mesenchymal Stem Cells/physiology , Mice , Multipotent Stem Cells
SELECTION OF CITATIONS
SEARCH DETAIL